Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDE4DIP pseudogene 2 (PDE4DIPP2) is a noncoding pseudogene related to the *Phosphodiesterase 4D interacting protein* gene (PDE4DIP). Unlike its parental gene, which encodes myomegalin—a structural and signaling protein involved in microtubule dynamics, cAMP signaling, and heart function—PDE4DIPP2 lacks protein-coding capacity due to disabling mutations. Bioinformatic analyses suggest that PDE4DIPP2 may participate in competitive endogenous RNA (ceRNA) networks, potentially regulating expression of the parental PDE4DIP gene via microRNA interactions in cancer cell contexts[2]. It is not recognized as a protein, receptor, enzyme, or drug target. No direct function, disease association, or drug interaction has been described for PDE4DIPP2, and it should not be confused with the protein-coding PDE4DIP gene product. - The parental gene, PDE4DIP, codes for a protein involved in cytoskeletal organization and cell signaling but PDE4DIPP2 itself does not code for a protein and thus does not have biochemical or therapeutic properties of interest[1][2][3][7]. - Some research suggests pseudogene transcripts like PDE4DIPP2 can affect gene regulation (e.g., via miRNA sponging), but such functions are indirect and currently of basic research interest only[2][5][9]. Summary: **PDE4DIP pseudogene 2 (PDE4DIPP2) is a noncoding pseudogene with no known direct therapeutic or functional biological relevance. It is not a therapeutic target. Its main relevance is possible regulatory RNA activity in gene expression networks, such as in cancer research, but it encodes no protein, is not a receptor or enzyme, and has no direct disease or drug associations.**
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDE4DIP pseudogene 2 (PDE4DIPP2).